Literature DB >> 22983575

A prospective study of nutritional status in immunoglobulin light chain amyloidosis.

Prayman T Sattianayagam1, Thirusha Lane, Zoe Fox, Aviva Petrie, Simon D J Gibbs, Jennifer H Pinney, Signe S Risom, Dorota M Rowczenio, Ashutosh D Wechalekar, Helen J Lachmann, Janet A Gilbertson, Philip N Hawkins, Julian D Gillmore.   

Abstract

Weight loss is common in systemic immunoglobulin light chain amyloidosis but there are limited data on the impact of nutritional status on outcome. Using the Patient-Generated Subjective Global Assessment (PG-SGA) score, we prospectively examined nutritional status in 110 consecutive newly-diagnosed, treatment-naïve patients with immunoglobulin light chain amyloidosis attending the UK National Amyloidosis Centre. At study entry, 72 of 110 (66%) patients had a PG-SGA score of 4 or over, indicating malnutrition requiring specialist nutritional intervention. Number of amyloidotic organs, elevated alkaline phosphatase, presence of autonomic neuropathy and advanced Mayo disease stage were independently associated with poor nutritional status (P<0.05). Quality of life was substantially poorer among those with higher PG-SGA scores (P<0.001). Furthermore, PG-SGA score was a powerful independent predictor of patient survival (P=0.02). Malnutrition is prevalent and is associated with poor quality of life and reduced survival among patients with systemic immunoglobulin light chain amyloidosis. The PG-SGA score would be an appropriate tool to evaluate whether nutritional intervention could improve patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983575      PMCID: PMC3533675          DOI: 10.3324/haematol.2012.070359

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  23 in total

1.  Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1.

Authors:  Riccardo Caccialanza; Giovanni Palladini; Catherine Klersy; Hellas Cena; Christina Vagia; Barbara Cameletti; Paola Russo; Francesca Lavatelli; Giampaolo Merlini
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

2.  The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers.

Authors:  C Persson; P O Sjödén; B Glimelius
Journal:  Clin Nutr       Date:  1999-04       Impact factor: 7.324

Review 3.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

4.  Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis.

Authors:  Digant Gupta; Christopher G Lis; Joel Granick; James F Grutsch; Pankaj G Vashi; Carolyn A Lammersfeld
Journal:  J Clin Epidemiol       Date:  2006-04-19       Impact factor: 6.437

5.  Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study.

Authors:  E Fiaccadori; M Lombardi; S Leonardi; C F Rotelli; G Tortorella; A Borghetti
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

6.  Malnutrition and food intake in relation to quality of life in head and neck cancer patients.

Authors:  E Hammerlid; B Wirblad; C Sandin; C Mercke; S Edström; S Kaasa; M Sullivan; T Westin
Journal:  Head Neck       Date:  1998-09       Impact factor: 3.147

Review 7.  Definition of standardized nutritional assessment and interventional pathways in oncology.

Authors:  F D Ottery
Journal:  Nutrition       Date:  1996-01       Impact factor: 4.008

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.

Authors:  L B Lovat; M R Persey; S Madhoo; M B Pepys; P N Hawkins
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary.

Authors:  L Ovesen; J Hannibal; E L Mortensen
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

View more
  3 in total

1.  Symptomatic involvement of the stomach and duodenum as initial presentation of AL amyloidosis.

Authors:  Faisal Inayat; Asad Ur Rahman; Effa Zahid; Nouman Safdar Ali; Roger Charles
Journal:  BMJ Case Rep       Date:  2019-01-17

Review 2.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

Review 3.  Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.

Authors:  Efstathios Kastritis; Ashutosh Wechalekar; Stefan Schönland; Vaishali Sanchorawala; Giampaolo Merlini; Giovanni Palladini; Monique Minnema; Murielle Roussel; Arnaud Jaccard; Ute Hegenbart; Shaji Kumar; Maria T Cibeira; Joan Blade; Meletios A Dimopoulos
Journal:  Br J Haematol       Date:  2020-07-04       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.